News Nectar Lifesciences Limited

Stocks

NECLIFE

INE023H01027

Pharmaceuticals

Delayed NSE India S.E. 07:45:23 29/10/2026 +04			5-day change	1st Jan Change
10.36 ^INR	+0.19%		-3.72%	-46.63%

09-18	Nectar Lifesciences Limited Appoints Dr. Gunmala Suri as A Non-Executive Non-Independent Director, Effective September 18, 2026	CI
08-15	Nectar Lifesciences Limited Changes Its Corporate Office in Chandigarh	CI

All News

Mentions Relevance

09-18	Nectar Lifesciences Limited Appoints Dr. Gunmala Suri as A Non-Executive Non-Independent Director, Effective September 18, 2026	CI
08-15	Nectar Lifesciences Limited Changes Its Corporate Office in Chandigarh	CI
08-14	Nectar Lifesciences Limited Announces Board and Committee Changes, Effective August 14, 2026	CI
08-14	Nectar Lifesciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
08-06	Nectar Lifesciences Limited Announces Resignation of Dr. Surulichamy Senthilkumar from Non-Executive Non-Independent Director, Effective August 06, 2026	CI
07-11	Nectar Lifesciences Limited Announces Change in Registered Office Address	CI
05-30	Nectar Lifesciences Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
03-06	Nectar Lifesciences Limited completed the acquisition of Avensis Exports Private Limited.	CI
03-02	Nectar Lifesciences to acquire 100% paid-up equity share capital of Avensis Exports	RE
03-02	Nectar Lifesciences Limited agreed to acquire Avensis Exports Private Limited for INR 2.5 million.	CI
01-23	Nectar Lifesciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
01-15	Tranche Update on Nectar Lifesciences Limited's Equity Buyback Plan announced on December 3, 2025.	CI
01-06	Nectar Lifesciences Limited's Equity Buyback announced on May 6, 2023, has closed with 30,000,000 shares, representing 13.38% for INR 810 million.	CI
12-20	Capnest Health Care Private Limited entered into Business Transfer agreement to acquire Empty Hard Gelatin Capsule unit at Bhatoli from Nectar Lifesciences Limited for approximately INR 200 million.	CI
12-03	Nectar Lifesciences approves buyback of shares valued at 810 million rupees	RE
12-03	Nectar Lifesciences Limited Appoints Sushil Kapoor as Additional Director and Whole-Time Director, Effective December 4, 2025	CI
12-03	Nectar Lifesciences Limited announces an Equity Buyback for 30,000,000 shares, representing 13.38% for INR 810 million.	CI
12-03	Nectar Lifesciences Limited authorizes a Buyback Plan.	CI
11-27	Nectar Lifesciences proposes buyback of equity shares	RE
11-27	Nectar Lifesciences Limited 's Board intends to launch an Equity Buyback on December 3, 2025.	CI
11-14	Nectar Lifesciences Limited Announces Changes in Registered and Corporate Offices	CI
11-12	Nectar Lifesciences Completes Slump Sale of API and Formulations Business; Shares Slip 3%	MT
11-11	Nectar Lifesciences Limited Announces Executive and Directorate Changes, Effective November 10, 2025	CI
11-11	Nectar Lifesciences Limited Announces Cessation of Amit Chadah as Chief Executive Officer, Effective November 10, 2025	CI
11-10	Ceph Lifesciences Private Limited completed the acquisition of manufacture, distribution, marketing and sale business of Nectar Lifesciences Limited for INR 12.54 billion.	CI